Patents by Inventor Tami LIVNAT

Tami LIVNAT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of ocular diseases
    Patent number: 11058750
    Abstract: Use of activated protein C (APC) for treatment and prevention of ocular diseases, disorders or conditions associated with retinal leakage and CNV such as age-related macular degeneration, optionally in combined therapy with anti-angiogenesis, anti-inflammatory, immunosuppressive, and anti PDGF agent.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: July 13, 2021
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Dov Weinberger, Tami Livnat, Yael Nisgav
  • COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISEASES
    Publication number: 20210206834
    Abstract: Methods for treating and/or preventing choroidal neovascularization (CNV) or retinal leakage associated with CNV are disclosed, comprising the use of activated protein C (APC) and/or an APC variant. A disclosed method may be applied in the treatment or prevention of ocular diseases, disorders or conditions that are caused directly by CVN, feature development of CNV as a secondary stage or a complication thereof, and/or feature CNV as a synchronous or asynchronous sequela thereof. An exemplary disease treatable by a disclosed method is neovascular age-related macular degeneration (nAMD).
    Type: Application
    Filed: January 21, 2021
    Publication date: July 8, 2021
    Inventors: Dov WEINBERGER, Tami LIVNAT, Yael NISGAV
  • COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISEASES
    Publication number: 20180271958
    Abstract: Use of activated protein C (APC) for treatment and prevention of ocular diseases, disorders or conditions associated with retinal leakage and CNV such as age-related macular degeneration, optionally in combined therapy with anti-angiogenesis, anti-inflammatory, immunosuppressive, and anti PDGF agent.
    Type: Application
    Filed: January 12, 2016
    Publication date: September 27, 2018
    Inventors: Dov WEINBERGER, Tami LIVNAT, Yael NISGAV